drugset / Trial / NCT00386191
Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment
RandomizedParallel-groupDouble-blindPrevention
Summary
The primary objective is to compare the safety of clopidogrel 50mg and 75mg in cerebral infarction with respect to incidence of bleeding adverse events.
Timeline
- Start
- 2006-09
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clopidogrel | Small molecule | 50 mg | Oral |
| Subject | Clopidogrel | Small molecule | 75 mg | Oral |